Cardiac monitoring-focused Biotelemetry acquires provider of clinical trial imaging services for $15.5M

Malvern PA's Biotelemetry has agreed to acquire VirtualScopics for $15.5 million to get its hands on clinical trial imaging services designed to accelerate partners' drug and device trials. The move broaden Biotelemetry's reach as it seeks to expand its focus beyond cardiac monitoring devices and services. The deal is just the latest example of med tech's growing role in improving the efficiency of clinical trials. Release | More

Suggested Articles

The FDA will be working with government and public-private partners to distribute and evaluate 3D designs and models.

The FDA issued a wide-ranging emergency policy allowing alternative devices to be used as potentially lifesaving ventilators amid new shortages.

Hospitals in the New York City area are turning to a private distributor to airlift millions of protective masks out of China.